The Xi'an Pharmaceutical Holdings Group Co., Ltd. has provided information to the company regarding the truthfulness, accuracy, and completeness of the information related to the judicial enforcement actions against shareholders holding over 5% of the shares.
Beijing Daxing Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") on April 30, 2026, published the announcement regarding the judicial enforcement actions against shareholders holding over 5% of the shares (Announcement No.: 2026-025), which affects 132,455,475 shares (accounting for 22.22% of the total share capital) of Xi'an Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as "Xi'an Pharmaceutical"). The enforcement will be carried out in accordance with the relevant laws and regulations.
The Company and the board of directors confirm that the content of this announcement is consistent with the information provided by the relevant parties.